Association between use of sodium-glucose co-transporter-2 inhibitor and the risk of incident dementia: a population-based cohort study
Many cases settle out of court
E.Yusuf SolaimanA.Tamr AghaK.MadmaniY.ShahrourY.EssaliA.et al
Alcohol comes back when GLP-1 use stops
Industry Funding: From the study, no industry funding source was reported, but conflicts included author relationships with AMRA Medical, Eli Lilly, BioMarin, Boehringer-Ingelheim/Lilly Alliance, Bayer, Novo Nordisk, AstraZeneca, Daiichi Sankyo, and related advisory, consulting, speaker, travel, employment, shareholder, and research-support roles
Common Side Effects Nausea Nausea is the most commonly reported side effect, particularly during the initial loading phase